These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2945973

  • 1. Good tolerance to high-dose hepatic arterial infusion therapy.
    Wile AG, Kasimis BS, Iyer P, Kaneshiro CA, Moran EM.
    J Surg Oncol; 1986 Nov; 33(3):207-11. PubMed ID: 2945973
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.
    Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315
    [Abstract] [Full Text] [Related]

  • 3. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ.
    Cancer; 1986 Feb 01; 57(3):465-70. PubMed ID: 2935242
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 01; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 5. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P.
    J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279
    [Abstract] [Full Text] [Related]

  • 6. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
    Barone RM, Byfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S.
    Cancer; 1982 Sep 01; 50(5):850-62. PubMed ID: 6212114
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001 Sep 01; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

  • 9. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG.
    Gan To Kagaku Ryoho; 1999 Feb 01; 26(3):269-81. PubMed ID: 10065089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
    Kemeny N, Cohen A, Bertino JR, Sigurdson ER, Botet J, Oderman P.
    Cancer; 1990 Jun 01; 65(11):2446-50. PubMed ID: 2140070
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.
    Rubin JT, Lotze MT, Rosenfelder D, Brumfield A, Howells R, Schwartz R, Sylvestri S, Sammon J, Bron K, Orens P.
    Ann Surg Oncol; 1995 Jul 01; 2(4):351-9. PubMed ID: 7552626
    [Abstract] [Full Text] [Related]

  • 14. Toxicity study of hepatic artery infusion chemotherapy with massive dose FUDR in rats.
    Zeng ZS, Zhang ZF, Sigurdson ER.
    Surg Oncol; 1995 Jun 01; 4(3):147-55. PubMed ID: 7582187
    [Abstract] [Full Text] [Related]

  • 15. Hepatobiliary toxicity of 5-fluoro-2'-deoxyuridine. Intra-arterial versus portal venous routes of infusion.
    Andrews JC, Kuntsen C, Terio P, Priescorn D, Ensminger WD.
    Invest Radiol; 1991 May 01; 26(5):461-4. PubMed ID: 1829068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy.
    Arisawa Y, Sutanto-Ward E, Fortunato L, Sigurdson ER.
    Ann Surg Oncol; 1995 Mar 01; 2(2):114-20. PubMed ID: 7537164
    [Abstract] [Full Text] [Related]

  • 18. Hepatic perfusion with FUdR utilizing an implantable system in patients with liver primary cancer or metastatic cancer confined to the liver.
    Seeger J, Woodcock TM, Blumenreich MS, Richardson JD.
    Cancer Invest; 1989 Mar 01; 7(1):1-6. PubMed ID: 2544247
    [Abstract] [Full Text] [Related]

  • 19. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.
    Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ.
    Ann Surg; 1985 Aug 01; 202(2):176-81. PubMed ID: 3160313
    [Abstract] [Full Text] [Related]

  • 20. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.
    Weiss GR, Garnick MB, Osteen RT, Steele GD, Wilson RE, Schade D, Kaplan WD, Boxt LM, Kandarpa K, Mayer RJ.
    J Clin Oncol; 1983 May 01; 1(5):337-44. PubMed ID: 6199474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.